/ZIVO

ZIVO Stock - ZIVO Bioscience, Inc.

Q: What is the analyst price target for ZIVO?

Analyst price target information is not currently available for ZIVO.

Q: What is ZIVO's market cap?

Market capitalization information is not currently available for ZIVO.

Healthcare|Biotechnology|OTC

$9.98+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+20.2%upside

Target: $12.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ZIVO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.20

52W High$22.15

52W Low$6.95

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$157,220	$27,650	N/A	N/A	$20,000
Gross Profit	$48,952	$11,610	N/A	N/A	$20,000
Gross Margin	31.1%	42.0%	N/A	N/A	100.0%
Operating Income	$-13,361,897	$-7,263,012	$-8,731,974	$-9,052,605	$-8,555,675
Net Income	$-13,384,836	$-7,777,184	$-8,745,293	$-9,396,647	$-9,655,783
Net Margin	-8513.4%	-28127.2%	N/A	N/A	-48278.9%
EPS	$-3.92	$-4.60	$-5.58	$-7.40	$-11.41

Company Overview

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Visit Website

Earnings History & Surprises

ZIVO

Beat Rate

21%

Last 14 quarters

Avg Surprise

-237.1%

EPS vs Estimate

Beats / Misses

3/10

1 met exactly

Latest EPS

$-0.27

Q4 2025

EPS Surprise History

Q1 24

-5.5%

$-0.96vs$-0.91

Q2 24

+41.3%

$-0.47vs$-0.80

Q3 24

-561.9%

$-2.78vs$-0.42

Q4 24

-71.8%

$-0.67vs$-0.39

Q1 25

+35.7%

$-0.36vs$-0.56

Q2 25

-115.4%

$-1.12vs$-0.52

Q3 25

-4.9%

$-0.43vs$-0.41

Q4 25

+25.0%

$-0.27vs$-0.36

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 13, 2026	—	—	—	—
Q4 2025	Nov 14, 2025	$-0.36	$-0.27	+25.0%	✓ BEAT
Q3 2025	Aug 14, 2025	$-0.41	$-0.43	-4.9%	✗ MISS
Q2 2025	May 15, 2025	$-0.52	$-1.12	-115.4%	✗ MISS
Q1 2025	Mar 18, 2025	$-0.56	$-0.36	+35.7%	✓ BEAT
Q4 2024	Nov 14, 2024	$-0.39	$-0.67	-71.8%	✗ MISS
Q3 2024	Aug 14, 2024	$-0.42	$-2.78	-561.9%	✗ MISS
Q2 2024	May 13, 2024	$-0.80	$-0.47	+41.3%	✓ BEAT
Q1 2024	Mar 15, 2024	$-0.91	$-0.96	-5.5%	✗ MISS
Q4 2023	Nov 13, 2023	$-1.05	$-1.05	0.0%	= MET
Q3 2023	Aug 14, 2023	$-0.20	$-1.32	-560.0%	✗ MISS
Q2 2023	May 10, 2023	$-0.24	$-1.26	-425.0%	✗ MISS
Q1 2023	Mar 14, 2023	$-0.21	$-1.68	-700.0%	✗ MISS
Q4 2022	Nov 14, 2022	$-0.23	$-1.26	-447.8%	✗ MISS
Q3 2022	Aug 4, 2022	$-0.21	$-1.32	-528.6%	✗ MISS
Q2 2022	May 13, 2022	—	$-1.32	—	—
Q2 2022	May 2, 2022	—	$-2.69	—	—
Q2 2022	Apr 22, 2022	—	$-2.04	—	—
Q3 2021	Aug 16, 2021	—	$-1.68	—	—
Q2 2021	May 17, 2021	—	$-4.80	—	—